Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymphatic matrix and lymph node reticuloendothelial cells represent a complex anatomical and cellular compartment rather than a single molecular target (Source: StatPearls, Reticuloendothelial System). This system includes the structural extracellular matrix of the lymphatic vessels and the phagocytic cells, such as macrophages and dendritic cells, that reside within the lymph nodes (Source: NIH, Lymphatic System). In clinical practice, this target is primarily relevant for diagnostic imaging, particularly in lymphoscintigraphy for sentinel lymph node mapping in cancers like breast cancer and melanoma (Source: FDA, Technetium Tc 99m Sulfur Colloid Label). Radiopharmaceuticals are administered interstitially and are subsequently transported via lymphatics, where they are either trapped in the matrix or internalized by reticuloendothelial cells (Source: PubChem, Technetium Tc 99m Tilmanocept). This process allows for the visualization of lymphatic drainage patterns and the identification of nodes most likely to harbor metastatic cells (Source: Journal of Nuclear Medicine, Lymphoscintigraphy). While essential for immune function and fluid homeostasis, this system's pharmacological relevance is currently limited to diagnostic localization and staging. Specific molecular interactions within this compartment include the binding of agents to the mannose receptor (CD206) on macrophages (Source: FDA, Lymphoseek Prescribing Information). Overall, it serves as a critical site for assessing cancer progression and immune status through targeted delivery of imaging agents.
Diagnostic agents are localized through physical entrapment within the lymphatic matrix or through active uptake (phagocytosis or receptor-mediated binding) by reticuloendothelial cells such as macrophages and dendritic cells (Source: FDA, Lymphoseek Prescribing Information; Source: StatPearls, Sulfur Colloid).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphatic matrix and lymph node reticuloendothelial cells.